LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

LLY

988.33

+0.72%↑

JNJ

240.32

+0.33%↑

ABBV

229.95

-0.9%↓

NVS

159.76

-0.49%↓

AZN

194.37

-1.51%↓

Search

Henry Schein Inc

Closed

SectorHealthcare

77.63 -3.16

Overview

Share price change

24h

Current

Min

76.67

Max

80.15

Key metrics

By Trading Economics

Income

-8M

101M

Sales

98M

3.4B

P/E

Sector Avg

25.669

66.845

EPS

1.34

Profit margin

2.939

Employees

25,000

EBITDA

1M

256M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+9.67% upside

Dividends

By Dow Jones

Next Earnings

4 May 2026

Market Stats

By TradingEconomics

Market Cap

97M

9.9B

Previous open

80.79

Previous close

77.63

News Sentiment

By Acuity

19%

81%

32 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Strong Bullish Evidence

Henry Schein Inc Chart

Past performance is not a reliable indicator of future results.

Related News

16 May 2025, 20:11 UTC

Acquisitions, Mergers, Takeovers

Henry Schein: William K. Daniel Joins Board

16 May 2025, 20:10 UTC

Acquisitions, Mergers, Takeovers

Henry Schein: Strategic Investment by KKR Completed

Peer Comparison

Price change

Henry Schein Inc Forecast

Price Target

By TipRanks

9.67% upside

12 Months Forecast

Average 87.92 USD  9.67%

High 100 USD

Low 61 USD

Based on 13 Wall Street analysts offering 12 month price targets forHenry Schein Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

13 ratings

6

Buy

6

Hold

1

Sell

Technical Score

By Trading Central

66.23 / N/ASupport & Resistance

Short Term

Strong Bullish Evidence

Intermediate Term

Bullish Evidence

Long Term

Strong Bearish Evidence

Sentiment

By Acuity

32 / 351 Healthcare

News Sentiment

Very Strong Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About Henry Schein Inc

Henry Schein, Inc. provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products, such as branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners; and value-added practice solutions comprising practice consultancy, education, revenue cycle management and financial services, e-services, practice technology, and network and hardware services, as well as consulting, and continuing education services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
help-icon Live chat